Is Veradermics, Inc (MANE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 3.1% / 30% | 0.1% / 30% | N/A | ✓ HALAL |
| DJIM | 0.0% / 33% | 3.1% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| MSCI | 0.0% / 33% | 95.6% / 33% | 2.5% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.0% / 33% | 3.1% / 33% | 0.1% / 33% | N/A | ✓ HALAL |
| FTSE | 0.0% / 33% | 95.6% / 33% | 2.5% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$24M |
| Free Cash Flow | -$24M |
| Current Ratio | 3.3 |
| Total Assets | $56M |
Price & Trading
| Last Close | $67.55 |
| 50-Day MA | $49.82 |
| 200-Day MA | $49.82 |
| Avg Volume | 452K |
|
52-Week Range
$32.00
| |
About Veradermics, Inc (MANE)
Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Veradermics, Inc (MANE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Veradermics, Inc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Veradermics, Inc's debt ratio?
Veradermics, Inc's debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.0%.
What are Veradermics, Inc's key financial metrics?
Veradermics, Inc has a market capitalization of $2.3B.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.